Intellia Therapeutics Inc (NTLA)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -16.601 | -20.007 | -23.59 | -29.206 | -26.565 | -27.186 | -33.695 | -34.114 |
| Return on Equity (%) | -33.54 | -26.465 | -29.504 | -36.339 | -33.686 | -34.185 | -41.672 | -42.104 |
| Return on Invested Capital (%) | -35.773 | -27.975 | -32.047 | -39.774 | -34.819 | -47.327 | -54.932 | -53.388 |
| Operating Margin (%) | -191.966 | -258.617 | -280.42 | -230.919 | -231.457 | -810.492 | -909.779 | -1326.511 |
| Net Profit Margin (%) | -191.966 | -258.617 | -280.42 | -230.919 | -231.457 | -810.492 | -909.779 | -1326.511 |
| Book Value Per Share | 5.826 | 7.092 | 6.145 | 5.376 | 7.958 | 13.966 | 14.185 | 11.727 |
| Earnings Per Share | -0.878 | -1.594 | -1.887 | -1.983 | -2.027 | -3.597 | -5.444 | -5.373 |
| Cash Per Share | 7.581 | 8.038 | 1.301 | 1.14 | 2.416 | 1.657 | 6.01 | 2.532 |
| Working Capital Per Share | 6.957 | 7.632 | 6.289 | 5.057 | 8.338 | 8.639 | 12.517 | 9.861 |
| Operating Profit Per Share | 0.458 | 0.616 | 0.673 | 0.859 | 0.876 | 0.444 | 0.598 | 0.405 |
| EBIT Per Share | -0.878 | -1.594 | -1.887 | -1.983 | -2.027 | -3.597 | -5.444 | -5.373 |
| EBITDA Per Share | -0.878 | -1.594 | -1.887 | -1.983 | -2.027 | -3.597 | -5.444 | -5.373 |
| Free Cash Flow Per Share | -0.738 | -1.426 | -1.845 | -1.959 | -2.068 | -3.518 | -5.375 | -5.317 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 36.02M | 42.39M | 45.22M | 50.2M | 66.23M | 74.49M | 87.1M | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 76.59M | 87.1M | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | -818.071 | N/A | N/A | N/A | -371.301 | N/A |
| Net Profit Margin (%) | N/A | N/A | -818.071 | N/A | N/A | N/A | -371.301 | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 1.02B |
| Price to Earnings Ratio | -2.22 |
| Price to Sales Ratio | 29.51 |
| Price to Cash Ratio | 4.72 |
| Price to Book Ratio | 1.02 |
| Dividend Yield | - |
| Shares Outstanding | 103.52M |
| Average Volume (1 week) | 4.12M |
| Average Volume (1 Month) | 3.66M |
| 52 Week Change | -65.91% |
| 52 Week High | 32.00 |
| 52 Week Low | 8.30 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
